上海国投孚腾资本等出资 中生引领基金成立

Core Insights - The establishment of Zhongsheng Leading (Shanghai) Private Equity Fund aims for a total target size of 1 billion yuan, with an initial closing size of 500 million yuan [1] - The fund is managed by Pudong Capital, a subsidiary of Pudong Venture Capital Group, and its initial investors include Shanghai Guotou Futeng Capital, Pudong Venture Capital Group, China National Pharmaceutical Group, and Hangzhou Kebaite [1] - The fund will focus on addressing the challenges of financing difficulties, long cycles, and high risks in the biopharmaceutical industry, promoting the industry's development towards high-end, international, and clustered directions [1]